This article is sponsored by DNA Genotek
In this exclusive video interview, Nutraceutical Business Review speaks with DNA Genotek’s director of product management, Héloïse Breton, about how microbiome science is enabling more evidence-based nutraceutical innovation. Drawing on her background in microbiome research, Breton explains how individual differences in gut microbiota influence responses to foods and supplements — and why this variability has long challenged nutraceutical efficacy.
She highlights the importance of microbiome sampling and stabilisation in generating reliable data, particularly in clinical and intervention studies, and outlines how analysing the microbiome before, during and after supplementation can help assess efficacy, mechanism of action and longer-term impact.
Breton also discusses the growing role of AI, bioinformatics and multi-omics in microbiome research, and shares her perspective on how integrating microbiome profiling into nutraceutical development could support more targeted, personalised and scientifically validated wellness solutions.
For more interviews with leading companies from across the nutraceutical industry, visit our YouTube channel and hit subscribe.
Nutraceutical Business Review in conversation with...
'Nutraceutical Business Review in conversation with' is a series of exclusive video interviews with leading companies in the nutraceutical industry, conducted by our team of B2B journalists.
For more information on how you can be part of 'Nutraceutical Business Review in conversation with' contact Chris Clark on +44 207 193 9012, or via email at chris@hpcimedia.com.
This interview was led by Annabel Kartal-Allen from Nutraceutical Business Review.